Literature DB >> 2838490

Survival following an extremely high-dose of mitoxantrone in a 73-year-old female with small cell bronchial carcinoma.

R Koppensteiner, E Minar, L Marosi, H Ehringer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2838490     DOI： 10.1007/BF00405844

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  2 in total

1.  Clinical safety and tolerance of mitoxantrone (Novantrone).

Authors:  R J Crossley
Journal:  Cancer Treat Rev       Date:  1983-12       Impact factor: 12.111

2.  Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.

Authors:  D D Von Hoff; T Chen; G M Clark; S K Callahan; R Livingston
Journal:  Cancer Treat Rep       Date:  1983-04
  2 in total
  1 in total

Review 1.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.